| Quantitative contribution of rs75017182 to dihydropyrimidine dehydrogenase mRNA splicing and enzyme activity Q Nie, S Shrestha, EE Tapper, CS Trogstad‐Isaacson, KJ Bouchonville, ... Clinical Pharmacology & Therapeutics 102 (4), 662-670, 2017 | 64 | 2017 |
| Gene‐specific variant classifier (DPYD‐Varifier) to identify deleterious alleles of dihydropyrimidine dehydrogenase S Shrestha, C Zhang, CR Jerde, Q Nie, H Li, SM Offer, RB Diasio Clinical Pharmacology & Therapeutics 104 (4), 709-718, 2018 | 60 | 2018 |
| Novel deleterious dihydropyrimidine dehydrogenase variants may contribute to 5‐fluorouracil sensitivity in an East African population T Elraiyah, CR Jerde, S Shrestha, R Wu, Q Nie, NH Giama, V Sarangi, ... Clinical Pharmacology & Therapeutics 101 (3), 382-390, 2017 | 45 | 2017 |
| YTHDF3 facilitates triple-negative breast cancer progression and metastasis by stabilizing ZEB1 mRNA in an m6A-dependent manner Y Lin, X Jin, Q Nie, M Chen, W Guo, L Chen, Y Li, X Chen, W Zhang, ... Annals of translational medicine 10 (2), 2022 | 37 | 2022 |
| Histone H3K27 trimethylation modulates 5-fluorouracil resistance by inhibiting PU. 1 binding to the DPYD promoter R Wu, Q Nie, EE Tapper, CR Jerde, GS Dunlap, S Shrestha, TA Elraiyah, ... Cancer research 76 (21), 6362-6373, 2016 | 21 | 2016 |
| Novel CTNND2‐TERT fusion in a spindle cell liposarcoma M Occidental, G Shen, X Feng, K Zhu, K Kelly, Q Nie, HV Reddi, ... Genes, Chromosomes and Cancer 59 (9), 544-548, 2020 | 9 | 2020 |
| Chromatin assembly factor 1 suppresses epigenetic reprogramming toward adaptive drug resistance Z Wang, R Wu, Q Nie, KJ Bouchonville, RB Diasio, SM Offer Journal of the National Cancer Center 1 (1), 15-22, 2021 | 8 | 2021 |
| Molecular profiling of CNS tumors for the treatment and management of disease Q Nie, MC Hsiao, H Chandok, S Rowe, M Prego, B Meyers, G Omerza, ... Journal of Clinical Neuroscience 71, 311-315, 2020 | 8 | 2020 |
| RNA-Seq for the detection of gene fusions in solid tumors: development and validation of the JAX FusionSeq™ 2.0 assay D Bergeron, H Chandok, Q Nie, M Prego, M Soucy, K Kelly, G Ananda, ... Journal of Molecular Medicine 100 (2), 323-335, 2022 | 7 | 2022 |
| Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor–Positive Human Epidermal Growth Factor Receptor-2–Negative Early … F Fu, L Yu, B Zeng, M Chen, W Guo, L Chen, Y Lin, J Hou, J Li, Y Li, S Li, ... JAMA Network Open 5 (2), e2145934-e2145934, 2022 | 6 | 2022 |
| Analytical validation and implementation of a pan cancer next-generation sequencing panel, CANSeqTMKids for molecular profiling of childhood malignancies KF Schilter, BA Smith, Q Nie, K Stoll, JC Felix, JA Jarzembowski, ... Frontiers in Genetics 14, 1067457, 2023 | 5 | 2023 |
| Methylation signatures as biomarkers for non-invasive early detection of breast cancer: A systematic review of the literature T Gonzalez, Q Nie, LN Chaudhary, D Basel, HV Reddi Cancer Genetics, 2023 | 3 | 2023 |
| High leukocyte mitochondrial DNA copy number contributes to poor prognosis in breast cancer patients W Zhang, S Lin, B Zeng, X Chen, L Chen, M Chen, W Guo, Y Lin, L Yu, ... BMC cancer 23 (1), 377, 2023 | 3 | 2023 |
| Molecular profiling of gynecologic cancers for treatment and management of disease–demonstrating clinical significance using the AMP/ASCO/CAP guidelines for interpretation and … Q Nie, G Omerza, H Chandok, M Prego, MC Hsiao, B Meyers, A Hesse, ... Cancer Genetics 242, 25-34, 2020 | 3 | 2020 |
| Mutation yield of a custom 212-gene next-generation sequencing panel for solid tumors: clinical experience of the first 260 cases tested using the JAX ActionSeq™ assay P Selvam, MC Hsiao, G Omerza, D Bergeron, S Rowe, J Uvalic, M Soucy, ... Molecular Diagnosis & Therapy 24, 103-111, 2020 | 2 | 2020 |
| Impact of body mass index in therapeutic response for HER2 positive breast cancer treated with neoadjuvant targeted therapy: a multi-center study and meta-analysis L Chen, F Wu, X Chen, Y Chen, L Deng, Q Cai, L Wu, W Guo, M Chen, ... NPJ Breast Cancer 9 (1), 46, 2023 | 1 | 2023 |
| MAZ-mediated up-regulation of BCKDK reprograms glucose metabolism and promotes growth by regulating glucose-6-phosphate dehydrogenase stability in triple-negative breast cancer Y Li, Y Lin, Y Tang, M Jiang, X Chen, H Chen, Q Nie, J Wu, X Tong, J Li, ... Cell Death & Disease 15 (7), 516, 2024 | | 2024 |
| YY1 mediated DCUN1D5 transcriptional activation promotes triple-negative breast cancer progression by targeting FN1/PI3K/AKT pathway Y Lin, Y Li, X Chen, X Jin, M Jiang, H Xiao, L Chen, M Chen, W Zhang, ... Biology Direct 19 (1), 42, 2024 | | 2024 |
| Evaluating direct amplification from viral transport medium for SARS-CoV-2 detection, strain typing, and angiotensin-converting enzyme genotyping and expression assays KF Schilter, S Kapoor, BA Smith, A Saleem, SJ Scott, D Batchelor, KA Stoll, ... Laboratory Medicine 55 (3), 267-270, 2024 | | 2024 |
| Additional prognostic value of polymorphisms within the 3′-untranslated region of programmed cell death pathway genes in early-stage breast cancer H Chen, M Chen, B Zeng, L Tang, Q Nie, X Jin, W Guo, L Chen, Y Lin, ... Frontiers in Immunology 15, 1284579, 2024 | | 2024 |
